Preoperative Cardiac Evaluation of Lung Resection Candidates

Thoracic Surgery Clinics

Volumn 18, Issue 1, 2008, Pages 45-59

  Cohn, Steven L ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUPIVACAINE; CORTICOSTEROID; DIGOXIN; DILTIAZEM; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; VERAPAMIL;

ANAMNESIS; CANCER DIAGNOSIS; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; COUNSELING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG USE; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE; EXERCISE TEST; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEMATOCRIT; HERBAL MEDICINE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; LUNG CANCER; LUNG EDEMA; LUNG FUNCTION TEST; LUNG RESECTION; METABOLIC BALANCE; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARDIAC EVALUATION; PREOPERATIVE EVALUATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SPIROMETRY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; THORAX PAIN; TREATMENT PLANNING; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; HEART FUNCTION TESTS; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; PNEUMONECTOMY; PREOPERATIVE CARE; RISK FACTORS;

EID: 38849149686     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2007.11.006     Document Type: Review

References (70)

1. American Cancer Society Statistics. Available at: http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf. Accessed November 5, 2007.
2. Qaseem A., Snow V., Fitterman N., et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 144 8 (2006) 575-580
3. Colice G.L., Shafazand S., Griffin J.P., et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132 Suppl 3 (2007) 161S-177S
4. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50 17 (2007) 1707-1732
5. Ghent W.S., Olsen G.N., Hornung C.A., et al. Routinely performed multigated blood pool imaging (MUGA) as a predictor of postoperative complications of lung resection. A two-year retrospective. Chest 105 5 (1994) 1454-1457
6. Cardinale D., Colombo A., Sandri M.T., et al. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation 115 11 (2007) 1339-1344
7. Kulier A., Levin J., Moser R., et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 116 5 (2007) 471-479
8. Wu W.C., Schifftner T.L., Henderson W.G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 22 (2007) 2481-2488
9. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 10 (1999) 1043-1049
10. Arozullah A.M., Daley J., Henderson W.G., et al. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg 232 2 (2000) 242-253
11. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 16 (1977) 845-850
12. Detsky A.S., Abrams H.B., Forbath N., et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 146 11 (1986) 2131-2134
13. Palda V.A., and Detsky A.S. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 127 4 (1997) 313-328
14. Hlatky M.A., Boineau R.E., Higginbotham M.B., et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 64 10 (1989) 651-654
15. Epstein S.K., Faling L.J., Daly B.D., et al. Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest 104 3 (1993) 694-700
16. Epstein S.K., Faling L.J., Daly B.D., et al. Inability to perform bicycle ergometry predicts increased morbidity and mortality after lung resection. Chest 107 2 (1995) 311-316
17. Melendez J.A., and Carlon V.A. Cardiopulmonary risk index does not predict complications after thoracic surgery. Chest 114 1 (1998) 69-75
18. Birim O., Maat A.P., Kappetein A.P., et al. Validation of the Charlson Comorbidity Index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 23 1 (2003) 30-34
19. Birim O., Kappetein A.P., and Bogers A.J. Charlson Comorbidity Index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 28 5 (2005) 759-762
20. Brunelli A., Fianchini A., Xiume F., et al. Evaluation of the POSSUM scoring system in lung surgery. Physiological and operative severity score for the enumeration of mortality and morbidity. Thorac Cardiovasc Surg 46 3 (1998) 141-146
21. Ferguson M.K., and Durkin A.E. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg 23 1 (2003) 35-42
22. Cagirici U., Nalbantgil S., Cakan A., et al. A new algorithm for preoperative cardiac assessment in patients undergoing pulmonary resection. Tex Heart Inst J 32 2 (2005) 159-162
23. Yano T., Yokoyama H., Fukuyama Y., et al. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg 11 3 (1997) 445-449
24. Licker M., de Perrot M., Hohn L., et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 15 3 (1999) 314-319
25. von Knorring J., Lepantalo M., Lindgren L., et al. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg 53 4 (1992) 642-647
26. Lim E., Li Choy L., Flaks L., et al. Detected troponin elevation is associated with high early mortality after lung resection for cancer. J Cardiothorac Surg 1 (2006) 37-45
27. Eagle K.A., Rihal C.S., Mickel M.C., et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 96 6 (1997) 1882-1887
28. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 27 (2004) 2795-2804
29. Ward H.B., Kelly R.F., Thottapurathu L., et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 82 3 (2006) 795-800 [discussion: 800-1]
30. Hassan S.A., Hlatky M.A., Boothroyd D.B., et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 110 4 (2001) 260-266
31. Ciriaco P., Carretta A., Calori G., et al. Lung resection for cancer in patients with coronary arterial disease: analysis of short-term results. Eur J Cardiothorac Surg 22 1 (2002) 35-40
32. Kaluza G.L., Joseph J., Lee J.R., et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 5 (2000) 1288-1294
33. Wilson S.H., Fasseas P., Orford J.L., et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 2 (2003) 234-240
34. Brichon P.Y., Boitet P., Dujon A., et al. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting. Eur J Cardiothorac Surg 30 5 (2006) 793-796
35. Marcucci C., Chassot P.G., Gardaz J.P., et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth 92 5 (2004) 743-747
36. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 6 (2007) 813-818
37. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 23 (1996) 1713-1720
38. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 24 (1999) 1789-1794
39. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 4 (2005) 349-361
40. Yang H., Raymer K., Butler R., et al. The effects of perioperative beta-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 5 (2006) 983-990
41. Brady A.R., Gibbs J.S., Greenhalgh R.M., et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 4 (2005) 602-609
42. Juul A.B., Wetterslev J., Gluud C., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 7556 (2006) 1482-1488
43. Redelmeier D., Scales D., and Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 331 7522 (2005) 932-938
44. Feringa H.H., Bax J.J., Boersma E., et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114 Suppl 1 (2006) I344-I349
45. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 5 (2006) 964-969
46. Devereaux P.J., Yang H., Guyatt G.H., et al. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152 2 (2006) 223-230
47. Wijeysundera D.N., Naik J.S., and Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114 9 (2003) 742-752
48. Wallace A.W., Galindez D., Salahieh A., et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101 2 (2004) 284-293
49. Kapoor A.S., Kanji H., Buckingham J., et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333 7579 (2006) 1149-1155
50. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 5 (2004) 967-975 [discussion: 975-6]
51. Feringa H.H., Schouten O., Karagiannis S.E., et al. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 50 17 (2007) 1649-1656
52. Schouten O., Hoeks S.E., Welten G.M., et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 100 2 (2007) 316-320
53. Schouten O., Kertai M.D., Bax J.J., et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 95 5 (2005) 658-660
54. Schouten O., Poldermans D., Visser L., et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 148 6 (2004) 1047-1052
55. De Decker K., Jorens P.G., and Van Schil P. Cardiac complications after noncardiac thoracic surgery: an evidence-based current review. Ann Thorac Surg 75 4 (2003) 1340-1348
56. Shrivastava V., Nyawo B., Dunning J., et al. Is there a role for prophylaxis against atrial fibrillation for patients undergoing lung surgery?. Interact Cardiovasc Thorac Surg 3 4 (2004) 656-662
57. Ulicny Jr. K.S., Schmelzer V., Flege Jr. J.B., et al. Concomitant cardiac and pulmonary operation: the role of cardiopulmonary bypass. Ann Thorac Surg 54 2 (1992) 289-295
58. Rosalion A., Woodford N.W., Clarke C.P., et al. Concomitant coronary revascularization and resection of lung cancer. Aust N Z J Surg 63 5 (1993) 336-340
59. Yokoyama T., Derrick M.J., and Lee A.W. Cardiac operation with associated pulmonary resection. J Thorac Cardiovasc Surg 105 5 (1993) 912-916 [discussion: 916-7]
60. Terzi A., Furlan G., Magnanelli G., et al. Lung resections concomitant to coronary artery bypass grafting. Eur J Cardiothorac Surg 8 11 (1994) 580-584
61. Thomas P., Giudicelli R., Guillen J.C., et al. Is lung cancer surgery justified in patients with coronary artery disease?. Eur J Cardiothorac Surg 8 6 (1994) 287-291 [discussion: 292]
62. Miller D.L., Orszulak T.A., Pairolero P.C., et al. Combined operation for lung cancer and cardiac disease. Ann Thorac Surg 58 4 (1994) 989-993 [discussion: 993-4]
63. Johnson J.A., Landreneau R.J., Boley T.M., et al. Should pulmonary lesions be resected at the time of open heart surgery?. Am Surg 62 4 (1996) 300-303
64. Rao V., Todd T.R., Weisel R.D., et al. Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg 62 2 (1996) 342-346 [discussion: 346-7]
65. Voets A.J., Joesoef K.S., and van Teeffelen M.E. Synchronously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach. Eur J Cardiothorac Surg 12 5 (1997) 713-717
66. Danton M.H., Anikin V.A., McManus K.G., et al. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature. Eur J Cardiothorac Surg 13 6 (1998) 667-672
67. Mariani M.A., van Boven W.J., Duurkens V.A., et al. Combined off-pump coronary surgery and right lung resections through midline sternotomy. Ann Thorac Surg 71 4 (2001) 1343-1344
68. Ambrogi V., Pompeo E., Elia S., et al. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 23 5 (2003) 811-817
69. Dyszkiewicz W., Jemielity M.M., Piwkowski C.T., et al. Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting). Ann Thorac Surg 77 3 (2004) 1023-1027
70. Schoenmakers M.C., van Boven W.J., van den Bosch J., et al. Comparison of on-pump or off-pump coronary artery revascularization with lung resection. Ann Thorac Surg 84 2 (2007) 504-509